Compare GNPX & AGMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNPX | AGMH |
|---|---|---|
| Founded | 2009 | 2015 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2M | 4.2M |
| IPO Year | 2018 | 2018 |
| Metric | GNPX | AGMH |
|---|---|---|
| Price | $2.00 | $2.16 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 311.5K | 36.6K |
| Earning Date | 11-14-2025 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 16.43 |
| Revenue | N/A | ★ $48,526,743.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.10 |
| Revenue Growth | N/A | ★ 18.80 |
| 52 Week Low | $1.71 | $1.09 |
| 52 Week High | $55.00 | $75.00 |
| Indicator | GNPX | AGMH |
|---|---|---|
| Relative Strength Index (RSI) | 38.75 | 38.21 |
| Support Level | $1.71 | $1.92 |
| Resistance Level | $1.88 | $2.50 |
| Average True Range (ATR) | 0.17 | 0.19 |
| MACD | 0.05 | 0.04 |
| Stochastic Oscillator | 39.53 | 33.68 |
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.
AGM Group Holdings Inc is an integrated technology company. The company focuses on blockchain-oriented ASIC chip design, high-end crypto miner production, and fintech technology software services. The company generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.